Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Noh, Sung Hoon, Park, Sook Ryun, Yang, Han-Kwang · The Lancet Oncology · 2014